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Abstract 
Background 
Dietary nitrate has been shown to increase nitrate/nitrite levels in multiple 
populations, with potential blood pressure lowering effects. However, there are few 
reports among hypertensives.  
 
Aims 
We aimed to assess the effect of daily nitrate in subject with controlled hypertension 
vs. uncontrolled hypertension.   
 
Methods 
On day 0, hypertensives wore an ambulatory BP monitor (ABPM) for 24h and fasting 
blood was taken. Subjects then consumed concentrated beetroot juice (12.9mmol 
nitrate) for 14 consecutive days. On day 14 subjects consumed their last nitrate dose 
after fasting blood was drawn and again had an ABPM for 24h.  
 
Results 
According to baseline ABPM, 11 subjects had controlled BP while 8 had uncontrolled 
BP. There were similar, significant increases in serum nitrate/nitrite in both groups. 
We observed little change in BP variables among controlled hypertensives. However, 
there were reductions in BP variables in uncontrolled hypertensives where decreases 
in nighttime DBP (-6 ± 4.8mmHg), arterial stiffness (-0.08 ± 0.03 ambulatory arterial 
stiffness index) and LDL (-0.36 ± 0.42mmol/L) reached significance (p=003, 0.05 and 
0.046 respectively).  
 
Abstract
Conclusions 
Our results support the existing data suggesting an anti-hypertensive effect of nitrate-
containing beetroot juice, but only among those with uncontrolled hypertension.  
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Abstract 76 
Background 77 
Dietary nitrate has been shown to increase nitrate/nitrite levels in multiple 78 
populations, with potential blood pressure lowering effects. However, there are few 79 
reports among hypertensives.  80 
 81 
Aims 82 
We aimed to assess the effect of daily nitrate in subject with controlled hypertension 83 
vs. uncontrolled hypertension.   84 
 85 
Methods 86 
On day 0, hypertensives wore an ambulatory BP monitor (ABPM) for 24h and fasting 87 
blood was taken. Subjects then consumed concentrated beetroot juice (12.9mmol 88 
nitrate) for 14 consecutive days. On day 14 subjects consumed their last nitrate dose 89 
after fasting blood was drawn and again had an ABPM for 24h.  90 
 91 
Results 92 
According to baseline ABPM, 11 subjects had controlled BP while 8 had uncontrolled 93 
BP. There were similar, significant increases in serum nitrate/nitrite in both groups. 94 
We observed little change in BP variables among controlled hypertensives. However, 95 
there were reductions in BP variables in uncontrolled hypertensives where decreases 96 
in nighttime DBP (-6 ± 4.8mmHg), arterial stiffness (-0.08 ± 0.03 ambulatory arterial 97 
stiffness index) and LDL (-0.36 ± 0.42mmol/L) reached significance (p=003, 0.05 and 98 
0.046 respectively).  99 
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Conclusions 101 
Our results support the existing data suggesting an anti-hypertensive effect of nitrate-102 
containing beetroot juice, but only among those with uncontrolled hypertension. 103 
Keywords: dietary nitrate, nitrite, nitric oxide, hypertension, blood pressure. 104 
 105 
 106 
 107 
 108 
 109 
 110 
 111 
 112 
 113 
 114 
 115 
 116 
 117 
 118 
 119 
 120 
 121 
 122 
 123 
 124 
 125 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  6 
Introduction 126 
Nitric oxide (NO) is a pluripotent molecule with diverse systemic effects, including 127 
systemic vasodilation [1] and blood pressure (BP) regulation [2]. NO bioavailability 128 
is reflected by levels of its metabolites; nitrate and nitrite [3]. Multiple studies have 129 
shown that NO metabolites are significantly lower in hypertension (HTN) compared 130 
to matched controls [4-7]. Additionally, serum NO levels have been reported to 131 
correlate negatively with both systolic and diastolic BP [7] and depend on dietary 132 
intake in HTN and ischemic stroke [8]. Therefore, dietary interventions to increase 133 
either the bioavailability or bioactivity of NO may have clinical utility in HTN.  134 
 135 
Until recently it was assumed that the only route for NO synthesis in vivo was via NO 136 
synthase (NOS) acting on its substrate, L-arginine. However, nitrite derived from 137 
dietary inorganic-nitrate has been shown to be a substrate for NOS-independent 138 
production of NO [9]. This involves both enzymatic and non-enzymatic reduction of 139 
nitrate to nitrite and to NO. Indeed, dietary nitrate has been shown to act as a 140 
precursor, in a dose-dependent manner, to nitrite and hence NO (10). Dietary nitrate 141 
has multiple cardioprotective effects as reviewed previously [11-13] and several 142 
authors have suggested that dietary nitrate is the major component responsible for the 143 
cardioprotective effect of vegetables [11, 13]. Further, a 2013 meta-analysis 144 
concluded that dietary nitrate can reduce systolic BP by 4.4mmHg (p<0.001) and 145 
diastolic BP by 1.1mmHg (p=0.06) among those without hypertension (14). There is a 146 
lack of data regarding dietary nitrate supplementation among hypertensives. However, 147 
two recent randomized, double-blind, placebo-controlled  trials of nitrate 148 
supplementation among hypertensives have emerged but 24h ABPM results were 149 
conflicting [15,16].  150 
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 151 
In this proof of concept study, we wanted to assess the effect of 14d dietary nitrate on 152 
ambulatory BP, arterial stiffness, serum nitrate/nitrite, lipids as well as renal and liver 153 
indices among treated hypertensives. We further wanted to assess any differences 154 
between controlled hypertensives and uncontrolled hypertensives as well as any 155 
potential adverse outcomes.  156 
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Materials and Methods  176 
Study design 177 
During this uncontrolled, pilot study, subjects were tested on two separate occasions, 178 
baseline (day 1) and endpoint (day 15)  (Fig. 1). On both days, in an identical manner 179 
and at the same time of day, fasting blood was drawn, the subject was fitted with an 180 
ambulatory blood pressure monitor (ABPM) for 24h and demographics, including 181 
body mass index as well as habitual dietary, exercise, smoking, alcohol and 182 
medication habits were recorded.  183 
 184 
Study participants 185 
We conducted an uncontrolled, pilot study of daily nitrate supplementation in 186 
clinically stable, Caucasian hypertensive outpatients, established on diverse 187 
antihypertensive regimens. We excluded subjects with kidney disease or diabetes and 188 
those on organic nitrates.  189 
 190 
This study was conducted according to the guidelines laid down in the Declaration of 191 
Helsinki and all procedures involving human subjects/patients were approved the 192 
Human Research Ethics Committee of Connolly Hospital, Dublin. Informed consent 193 
was obtained from all individual participants included in the study. 194 
 195 
Beetroot juice 196 
All subjects were asked to consume 140ml beetroot juice (BRJ) daily for 14 197 
consecutive days. We selected this dose (12.9mmol nitrate) as the nitrate content is 198 
attainable with a diet rich in vegetables [17]. During the trial all subjects were 199 
provided with written and verbal instructions not to alter dietary, tobacco, alcohol, 200 
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exercise or medication habits and not to use mouthwash, which is a known inhibitor 201 
of dietary nitrate reduction to nitrate [18]. Subjects took their 14th and final dose of 202 
BRJ after their second fasted blood sample, while wearing the ABPM for a second 203 
occasion. Compliance with the BRJ was assessed with a daily diary. 204 
 205 
Outcome measures 206 
Twenty four hour ambulatory blood pressure measurement 207 
24h ABPM was performed on day 1 and day 15 using the non-invasive ABPM 208 
Spacelabs 90207 machine (Spacelabs Healthcare Ltd., Issaquah, WA, USA). For each 209 
assessment, the ABPM was fitted on the upper left arm by a researcher (CPK) in the 210 
morning after 10 minutes of quiet rest.  211 
 212 
An initial BP reading was taken in the clinic and subjects were asked to return to the 213 
clinic wearing the ABPM 24h later. The device was programmed to record BP every 214 
30mins between the hours of 07.00 and 23.00 and every 60mins from 23.00 to 07.00. 215 
Participants were advised that they could carry out their usual activities but to avoid 216 
strenuous exercise. For each BP measurement, volunteers were asked to hang their 217 
arm loosely down the side of their body while keeping still until the end of the 218 
measurement. If active, the volunteers were instructed to stop and remain stationary 219 
while the measurement was being recorded. Proprietary software was used to 220 
download readings and produce 24h, daytime (0700–2300 hours) and nighttime 221 
(23:00– 07:00 hours) mean BP readings (90256 ABP Report Management System; 222 
Spacelabs Healthcare). We defined uncontrolled HTN as either baseline 24h SBP 223 
>130mmHg or 24h DBP >80mmHg as recorded with APBM and controlled BP as 224 
<130/80mmHg [19]. Ambulatory arterial stiffness index (AASI) was derived from 225 
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individual 24h ABPM whereby, regression slope of diastolic BP on systolic BP was 226 
computed. AASI was defined as 1 minus the regression slope, as previously described 227 
[21].  228 
 229 
Biochemical analysis 230 
On day 1 and 15, two fasting, venous blood samples were drawn into serum tubes 231 
(Sarstedt Monovette Serum Z) which have a low nitrate/nitrite content before ABPM 232 
set up. One tube was analyzed locally in our clinical laboratory for routine lipid 233 
parameters (total cholesterol, LDL, HDL), liver (albumin, calcium, urea) and renal 234 
(sodium, potassium, creatinine) parameters.  235 
 236 
The second tube was centrifuged at 4,000RPM and 4°C for 10m immediately after 237 
phlebotomy. Serum was subsequently extracted into Eppendorf tubes and frozen at 238 
−80°C and later analyzed for NO metabolites (nitrate/nitrite), which reflect NO 239 
bioavailability [3] as previously described [20]. 240 
 241 
Statistical methods 242 
For this pilot study we did not perform a power calculation. Paired t-tests were used 243 
to compare baseline and post BRJ values for each group while unpaired t-tests were 244 
used to compare controlled and uncontrolled HTN. Results were expressed as mean ± 245 
standard deviation. All statistical tests were conducted at the two-sided 0.05 246 
significance level using SAS (version 9.0). 247 
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Results 251 
Study population 252 
Of the 55 subjects we screened, twenty subjects were recruited. There was a single 253 
drop out (female, 61y, BMI=33.6kg/m2) due to acute complication of an underlying 254 
pulmonary issue (unrelated to study). The baseline characteristics of the 19 subjects 255 
who completed this pilot study are displayed in table 1. Both groups were composed 256 
mainly of males. There was no difference in baseline BMI but the uncontrolled group 257 
were significantly younger (49 vs. 60.9y; p=0.023). There was little difference in anti-258 
hypertensive use among the groups (1.5 agents per subject in controlled vs. 1.1 agents 259 
per subject in uncontrolled). Throughout the study, there was no reported change in 260 
prescribed medication, or habitual diet/exercise between visits.  261 
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Table 1: Baseline characteristics 276 
 Controlled (n 11) Uncontrolled (n 8) P-value 
 Mean SD Mean SD  
Age (years) 60.9 9.1 49.3 14.5 0.023 
Male gender n (%) 10 (91)  7 (88)  - 
BMI (kg/m2) 30.8 2.4 29.5 6.0 0.3 
Weight category*      
Healthy range n (%) 0 (0)  2 (25)  - 
Overweight n (%) 3 (27)  3 (38)  - 
Obese n (%) 8 (73)  3 (38)  - 
Smoking status (n)      
Current smoker 0  2 (25)  - 
Ex-smoker 7 (64)  4 (50)  - 
LLNS 4 (36)  2 (25)  - 
Baseline systolic BP 124 14.0 136 11.0 0.035 
Baseline diastolic BP 73 9.0 89 8.0 0.0004 
Average No. BP meds 1.5  1.1  - 
Aspirin n 2  4  - 
Statin n 4  4  - 
Co-morbidities      
Cerebrovascular 
disease n 
4  1  - 
Coronary artery 
disease n 
2  2  - 
Hypercholesterolaemia 
n 
4  2  - 
BP, blood pressure; LLNS, life-long non-smoker 277 
 278 
Biochemistry 279 
Baseline serum nitrate was 116% higher in the uncontrolled group compared to the 280 
controlled group but this was not significant (23.6 vs. 50.9μM; p=0.09). In contrast, 281 
baseline serum nitrite was 14% lower in the in the uncontrolled group compared to 282 
the controlled group. Again this was not significant (98.2 vs. 86.2nM; p=0.25) (table 283 
2).  284 
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Table 2: Biochemical indices before and after nitrate supplementation (BRJ) 290 
 Controlled Uncontrolled  
 
 Pre-BRJ Post-
BRJ 
Absolute 
change 
* P-
value 
Pre-BRJ Post-
BRJ 
Absolute 
change 
* P-
value 
# P-value 
 
Nitrate 
(μM ) 
23.6 181.6 158 0.0018 50.9 155.3 104.4 0.016 0.38 
Nitrite 
(nM) 
98.2 174.3 76.1 0.011 86.2 163.7 77.5 0.007 0.89 
BRJ, beetroot juice 291 
* p-values are derived from paired t-tests of the absolute change within each group 292 
# p-values derived from unpaired t-tests of the absolute changes between groups.  293 
 294 
Fasting serum nitrate increased by 770% and 310% in the controlled and uncontrolled 295 
groups respectively. Similarly, serum nitrite increased 177% and 190% in the 296 
controlled and uncontrolled groups respectively. However, these differences did not 297 
reach statistical significance (table 2). Mean LDL concentrations decreased in 7 of 8 298 
subjects in the uncontrolled group (and this reduction was significant compared to the 299 
controlled group (3.35 ± 0.47 to 2.99 ± 0.64 vs 2.14 ± 0.67 to 2.47 ± 0.87; p=0.023). 300 
There were no significant differences in any other lipid, liver or renal parameters 301 
within or between groups (data not shown). 302 
 303 
Ambulatory blood pressure 304 
Average ABPM wear time was 23.3h at baseline and 22.8 at endpoint, with a mean of 305 
34.5 successful readings taken per subject at both baseline and endpoint. Mean group 306 
values for 24h, day and night systolic and diastolic BP as well as ambulatory arterial 307 
stiffness index (AASI) are displayed in table 3. Consumption of dietary nitrate was 308 
not associated with decreased 24h, day or night BP in the controlled hypertensives. In 309 
contrast after nitrate consumption, there were reductions in night BP and arterial 310 
stiffness in the uncontrolled hypertensives (table 3).  311 
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Table 3: Ambulatory blood pressure monitor results 314 
 Controlled Uncontrolled  
 Pre-BRJ Post-BRJ Absolute 
change 
* P-value Pre-BRJ Post-BRJ Absolute 
change 
* P-value # P-value 
 
24h 
SBP 
123.7 ± 
13.7 
126.8 
±16.6 
3.1 0.2 135.7 133.1 -2.6 0.29 0.09 
24h 
DBP 
72.3 ± 
8.7 
75 ± 10.7 2.7 0.078 88.8 86.1 -2.7 0.15 0.026 
Day 
SBP 
126.2 ± 
13.7 
127.5 ± 
17.6 
1.3 0.42 136.4 136.1 -0.3 0.48 0.33 
Day 
DBP 
74.5 ± 
9.4 
75.7 ± 10 1.2 0.39 89.8 88.9 -1 0.42 0.2 
Night 
SBP 
118.2 ± 
15.4 
121.1 ± 
15.8 
2.9 0.37 125.8 119 -6.8 0.11 0.07 
Night 
DBP 
66.5 ± 
9.1 
72.1 ± 
12.8 
5.6 0.08 80.3 74.3 -6 0.03 0.0058 
Night 
SBP 
max 
134.8  ± 
20 
139.6  ± 
19  
4.8 0.37 145.3  ± 
9.6 
135  ± 
11.6 
-10.3 0.1 0.064 
Night 
DBP 
max 
79.5  ± 
20.4 
85.4  ± 
17 
5.9 0.18 94.5  ± 
6.3 
88.1  ± 
13.3 
-6.4 0.26 0.083 
AASI 0.43  ± 
0.2 
0.48  ± 
0.18 
0.05 0.13 0.42  ± 
0.13 
0.34  ± 
0.11 
-0.08 0.05 0.1 
%SBP 
Dipping 
6.2  ± 9.1 4  ± 11.1 -2.2 0.64 9.2  ± 4 13.7  ± 
5.3 
4.5 0.13 0.21 
%DBP 
Dipping 
11  ± 8.1 5.1  ± 
12.8 
-5.9 0.21 11.7  ± 
6.6 
17.5  ± 8 5.8 0.09 0.04 
AASI, ambulatory arterial stiffness index; BRJ, beetroot juice; DBP, diastolic blood pressure; SBP, 315 
systolic blood pressure. 316 
* p-values are derived from paired t-tests of the absolute change within each group. 317 
# p-values derived from unpaired t-tests of the absolute changes between groups.  318 
 319 
Adverse events 320 
There were no reported adverse events. The BRJ was well tolerated and as reported 321 
previously [16], 8 subjects (38%) reported transient, red/pink urine (beetruria). 322 
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Discussion 328 
In this proof of concept study, we demonstrate that daily, nitrate-rich beetroot juice 329 
for 14d led to increased NO bioavailability in both controlled and uncontrolled HTN 330 
and reductions night BP, AASI as well as LDL cholesterol in uncontrolled 331 
hypertensives only. Further, the intervention was well-tolerated, safe and did not lead 332 
to excessive BP lowering in controlled HTN.  333 
 334 
Nitrate-rich beetroot juice was associated with significant increases in both serum 335 
nitrate and nitrite in controlled and uncontrolled hypertensives. These increases were 336 
less than observed in previous, acute studies utilizing the same dose of nitrate [16,17]. 337 
In this context it is important to note that we collected fasting blood samples and 338 
therefore the BRJ would have been consumed 12-24h prior to blood collection. 339 
Considering the peak increase in plasma nitrate and nitrite due to exogenous nitrate 340 
occurs 2-3h following ingestion [22] it is understandable that the increases in serum 341 
nitrate and nitrite we observed were blunted compared to previous studies. It is 342 
noteworthy that all subjects had fasting blood samples taken on both day 1 and 15 and 343 
were then fitted with the ABPM before consuming BRJ – therefore ABPM recordings 344 
were conducted while nitrate was bioactive. 345 
 346 
Here, we observed decreases in BP profiles in uncontrolled hypertensives only. The 347 
effects were most apparent in nighttime DBP (p=0.03), DBP dipping (p=0.09). 348 
Although, other variables did not reach statistical significance, this proof of concept 349 
study included a small sample and was not powered to detect statistically significant 350 
results. In this context, our observations are clinically significant. Since the discovery 351 
that dietary nitrate can increase NO bioavailability, much research has focused on its 352 
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anti-hypertensive potential. A 2013 meta-analysis concluded that dietary nitrate can 353 
reduce systolic BP by 4.4mmHg (p<0.001) and diastolic BP by 1.1mmHg (p=0.06) in 354 
those without hypertension [14]. Despite much recent interest in the anti-hypertensive 355 
effect of dietary nitrate, most of the trials in this meta-analysis were of short duration 356 
(2h to 15d) and assessed young, healthy adults. There is a lack of interventional data 357 
among hypertensives. A 2013 pilot study, provided evidence that dietary nitrate was a 358 
plausible antihypertensive agent. In a small cohort of untreated, stage 1 hypertensives 359 
exogenous nitrate increased plasma nitrite 150% and this was associated with 360 
decreases in mean 24h in systolic- (-11.2mmHg; p<0.001) and diastolic-blood 361 
pressure (-9.6mmHg; p<0.001) [23]. Two recent, well-conducted trials provided 362 
conflicting evidence, one demonstrating benefit [15] and another, no effect [16]. 363 
These differences may be due to differing dosing regimens, intervention periods and 364 
patient demographics including BMI, age and medications. Our results suggest that 365 
any reduction of BP in treated hypertensives may be greatest among those with higher 366 
initial BP and after ≥7d of nitrate dosing. This observation is consistent with previous 367 
studies [15, 16, 24]. 368 
 369 
Plasma nitrite reflects flow mediated dilation (FMD) [25] and through its 370 
bioactivation to NO is recognized to be a critical pathway regulating basal vascular 371 
tone, arterial stiffness and BP [25, 26]. Therefore altering plasma nitrite, including by 372 
dietary means, has potential to affect endothelial function and arterial stiffness. In 373 
addition to BP reduction, we also observed a significant reduction in arterial stiffness 374 
(p=0.05). Previous randomized, controlled crossover trials have demonstrated that 375 
dietary nitrate can significantly decrease arterial stiffness and significantly improve 376 
endothelial function in healthy subjects acutely (2-6 hours) in conjunction with 377 
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significantly increased NO metabolites [22-31] These studies utilized nitrate doses 378 
varying from 1.1-22.5mmol. Further, 20 healthy overweight/ slightly obese men were 379 
randomized to a high fat meal with nitrate-rich BRJ (8.1mmol nitrate) or nitrate-380 
depleted BRJ. Postprandial impairment in FMD was improved after the nitrate-rich 381 
BRJ compared with placebo (-0.37% vs -1.56%; p=0.03) [31]. Further, the effect 382 
appears to be maintained as evidenced by longer trials (7d) [30]. However, 7d of a 383 
high-nitrate diet (4.84mmol nitrate/day from green leafy vegetables) compared to a 384 
low-nitrate diet did not affect multiple BP variables or arterial stiffness among 38 385 
middle aged adults with high–normal BP (SBP=120-139mmHg) [32]. Nevertheless, a 386 
double-blind, randomized, controlled trial of drug-treated (n=34) and drug-naïve 387 
(n=34) hypertensives demonstrated that 28d of 6.4mmol nitrate improved endothelial 388 
function (FMD) by ~20% (P<0.001) and reduced arterial stiffness (as assessed by 389 
pulse wave velocity) by 0.59 m/s (0.24-0.93; P<0.01) [15].  390 
 391 
We also demonstrate for the first time that 14d dietary nitrate significantly decreased 392 
serum LDL among 8 subjects with uncontrolled HTN. According to the Third Report 393 
of The National Cholesterol Education Program [33], baseline LDL levels in the 394 
uncontrolled hypertensives were in the ‘borderline high’ category. After 14d dietary 395 
nitrate, LDL levels were ‘near optimal/above optimal’ category (p=0.046). This 396 
reduction was specific to the uncontrolled HTN group and was significant compared 397 
to controlled hypertensives (p=0.023). This observation is interesting, particularly in 398 
light of our small sample size, short intervention period and considering there was no 399 
change in diet, exercise or medications, including antihyperlipidaemic medications. 400 
We cannot however, rule out a type one error, particularly because we are not aware 401 
of any human intervention study involving provision of dietary nitrate which reported 402 
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cholesterol or its subfractions. In this context, it is interesting that decreased basal 403 
plasma nitrate/nitrite level has been reported in hypercholesterolemic subjects with 404 
suspected coronary artery disease but not in normocholesterolemic subjects [34]. 405 
Hypercholesterolemia may reduce the NO bioavailability and several explanations 406 
have been offered for this, including decreased availability of L-arginine, the substrate 407 
for NOS [35]; decreased synthesis of NO through degeneration of endothelial G-408 
protein or G-protein-dependent pathways [36] and reduced expression of endothelial 409 
NOS [37, 38]. Further, plasma nitrate/nitrite levels have previously been reported to 410 
correlate negatively with both total cholesterol (r = -0.40, p<0.01) and LDL 411 
cholesterol levels (r=-0.37, p<0.003) [34]. Interestingly statins, widely prescribed for 412 
their cholesterol lowering properties activate endothelial NOS [39]. Further, there is 413 
evidence that 8 weeks of dietary nitrate (100 mg/L in drinking water) reduced LDL 414 
cholesterol in normal (1.12 to 0.75mmol/L; p<0.05) and diabetic rats (1.12 to 415 
0.46mmol/L; p<0.05) compared to normal and diabetic rats without nitrate [40]. 416 
Although, our study cannot provide mechanistic insight for the LDL reductions, our 417 
data provide preliminary evidence for the first time that dietary nitrate reduces LDL 418 
levels in uncontrolled hypertensive patients. This observation is consistent with 419 
preliminary research suggesting that nitrate targets a novel pathway to enhance fat 420 
metabolism and/or energy utilization [41] and decreases lipid levels in animal models 421 
[40-42].  422 
 423 
NO has multiple roles in cardio-metabolic regulation. Several comprehensive reviews 424 
have highlighted the diverse cardioprotective effects of dietary nitrate [11-13]. Some 425 
authors have even suggested that dietary nitrate is the major component responsible 426 
for the cardioprotective effect of vegetables [11, 12]. It has been demonstrated that 427 
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dietary nitrate acts as a precursor to NO in a dose-dependent mannerwhereby a single 428 
serving of a nitrate-rich vegetables contains more nitrate than what is formed 429 
endogenously by the all three NOS isoforms combined in 24h [9]. Dietary nitrate 430 
increases vasodilation as well as inhibiting production of mitochondrial reactive 431 
oxygen species and platelet aggregation. Despite the complex nature of NO and the 432 
multiple contributors to NO bioavailability (e.g. underlying pathology, medication 433 
use, serum lipids, tobacco exposure, exercise, alcohol intake), diet has been shown to 434 
be the major influencer of serum NO in patients with HTN and ischemic stroke [8].  435 
In this context, our results and those of others should not be considering surprising. 436 
 437 
This trial has several key strengths. The use of 24h ABPM provides a robust, reliable 438 
method of determining BP. We asked subjects to maintain their typical dietary, 439 
exercise, alcohol, tobacco and medication habits throughout this study. Therefore our 440 
observations closely reflect that effect of supplementary nitrate to the everyday lives 441 
of hypertensives. The increases in serum nitrate and nitrite confirmed compliance 442 
with the intervention.  443 
 444 
This pilot study did not include a control arm or a placebo. Therefore, it is possible 445 
that any observed effect was simply regression to the mean. It is also possible that any 446 
effect observed here may be due to non-nitrate components of beetroot juice. 447 
However, emerging trials utilizing nitrate-rich beetroot juice and identical, nitrate-448 
depleted beetroot juice have demonstrated no physiological effect of nitrate-depleted 449 
beetroot juice. Further, our results are consistent with a recent meta-analysis [14] and 450 
a double-blin, randomized, placebo-controlled trial [15]. Therefore we suggest that 451 
our observations are due to dietary nitrate. The number of participants in our study (n 452 
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= 19) may be considered small. However, many previous studies investigating 453 
chronic nitrate intake on BP had similar numbers [16, 24]. 454 
 455 
In this pilot study, we observed significant decreases in night DBP, AASI and LDL 456 
cholesterol in conjunction with increased serum NO metabolites. These effects were 457 
confined to subjects with uncontrolled BP, suggesting that the physiological effects of 458 
exogenous nitrate may be greatest in these patients.  Considering the conflicting data 459 
in the area, our pilot results should be confirmed with well-designed trials, 460 
particularly regarding LDL.  461 
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Ethical approval:  478 
“All procedures performed in studies involving human participants were in 479 
accordance with the ethical standards of the institutional and/or national research 480 
committee and with the 1964 Helsinki declaration and its later amendments or 481 
comparable ethical standards.” 482 
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